Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Mapping the Vif-A3G interaction using peptide arrays: a basis for anti-HIV lead peptides

Published

Author(s)

Jeeseong Hwang, Ji Y. Lee, Abigail E. Miller, Tali Reingewertz, Elena Britan-Rosich, Shahar Rotem-Bamberger, Mathias Viard, Robert Blumenthal, Assaf Friedler

Abstract

Human apolipoprotein-B mRNA-editing catalytic polypeptide-like 3G (A3G) is a cytidine deaminase that restricts retroviruses, endogenous retro-elements and DNA viruses. A3G plays a key role in the anti- HIV-1 innate cellular immunity. The HIV-1 Vif protein counteracts A3G mainly by leading A3G towards the proteosomal machinery and by direct inhibition of its enzymatic activity. Both activities involve direct interaction between Vif and A3G. Disrupting the interaction between A3G and Vif may rescue A3G antiviral activity and inhibit HIV-1 propagation. Here, mapping the interaction sites between A3G and Vif by peptide array screening revealed distinct regions in Vif important for A3G binding, including the N-terminal domain (NTD), C-terminal domain (CTD) and residues 83-99. The Vif-binding sites in A3G included 12 different peptides that showed strong binding to either full-length Vif, Vif CTD or both. Sequence similarity was found between Vif-binding peptides from the A3G CTD and NTD. A3G peptides were synthesized and tested for their ability to counteract Vif action. A3G 211-225 inhibited HIV-1 replication in cell culture and impaired Vif dependent A3G degradation. In vivo co-localization of full-length Vif with A3G 211-225 was demonstrated by use of FRET. This peptide has the potential to serve as an anti-HIV-1 lead compound. Our results suggest a complex interaction between Vif and A3G that is mediated by discontinuous binding regions with different affinities.
Citation
Bioorganic & Medicinal Chemistry
Volume
21
Issue
12

Keywords

protein-protein interactions, peptide arrays, Vif, HIV-1, Apobec-3G, A3G

Citation

Hwang, J. , Lee, J. , Miller, A. , Reingewertz, T. , , E. , Rotem-Bamberger, S. , Viard, M. , Blumenthal, R. and , A. (2013), Mapping the Vif-A3G interaction using peptide arrays: a basis for anti-HIV lead peptides, Bioorganic & Medicinal Chemistry, [online], https://doi.org/10.1016/j.bmc.2013.03.001 (Accessed June 14, 2024)

Issues

If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.

Created June 15, 2013, Updated November 10, 2018